Quality-of-life considerations in patients with uveal melanoma: a systematic review.

CONCLUSIONS: Overall, there is no significant difference in long-term QOL in patients with UM from different treatment groups past 1-year follow-up. This work underscores the need for and importance of developing a standardized, complete assessment tool tailored to the challenges inherent to the diagnosis of UM. PMID: 32649871 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32649871?dopt=Abstract

Source: Canadian Journal of Ophthalmology - July 6, 2020 Category: Opthalmology Authors: Anchouche S, Liu J, Zaguia F, Nassrallah G, Deschênes J Tags: Can J Ophthalmol Source Type: research